Evaluation in a Multicenter, Prospective, Observational Study
2017
Results: The mortality rate for patients with candidemia was 34%. The mortality rate for patients with catheter-related candidemia in whom the catheters were retained was significantly higher than that of patients in whom the catheters were removed (41% vs 21%, P 500 mg) (15%), but the group treated with a low dose had fewer side effects (40%) than those treated with a high dose (55%) (P=.03). Fluconazole was as efficacious as amphotericin B in the therapy of candidemia, even when stratified by risk factors for mortality. Fewer side effects were seen with fluconazole (12%) compared with amphotericin B (44%) (P<.001). Conclusions: In selected patients with candidemia, low\x=req-\ dose amphotericin B was as efficacious as high-dose amphotericin B. Based on other studies and ours, fluconazole seems to be an alternative therapeutic option to amphotericin B in selected patients. (Arch Intern Med. 1995;155:2429-2435)
Keywords:
- Correction
- Cite
- Save
- Machine Reading By IdeaReader
6
References
0
Citations
NaN
KQI